Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page’s footer “Revision” version was increased from v3.5.2 to v3.5.3, indicating a backend/software release update without changing the study information presented.SummaryDifference0.1%

- Check12 days agoChange DetectedAddition: Revision v3.5.2; Deletion: Revision v3.5.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedThe site footer revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check48 days agoChange DetectedThe site revision displayed changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedSite update to revision v3.4.2; the funding/operating status notice has been removed and there are no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedNotice banner warns that information may not be up to date due to a lapse in government funding and provides operating status links. The page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.